Budget: 4 502 080,00 $

Start date: 01 April 2013 End date: 31 March 2017

GE³LS Study: Development of an evidence base and evaluation toolkits (economic, regulatory, legal, commercial and social values-based) to increase transparency and understanding among the main stakeholders to enhance the adoption high-value personalized medicine treatments in Canada.

To learn more on this project.